Treatment of eosinophilic myositis with mepolizumab
Saved in:
Main Authors: | Saadia Waheed, Hafiz Muhammad Zubair, Farishta Waheed |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-01-01
|
Series: | Indian Journal of Rheumatology |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=4;spage=289;epage=290;aulast=Waheed |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elevated mepolizumab levels in patients with severe asthma responsive to 1 year’s mepolizumab treatment
by: Takayasu Nishimaki, MD, et al.
Published: (2025-05-01) -
Improvement of Chronic Rhinosinusitis and Reduction of the Myeloperoxidase-Antineutrophil Cytoplasmic Antibody Titer in a Patient with Eosinophilic Granulomatosis with Polyangiitis by Additional Mepolizumab
by: Shin-ya Tamechika, et al.
Published: (2021-01-01) -
Serum Levels of Epithelial-Derived Cytokines as Interleukin-25 and Thymic Stromal Lymphopoietin after a Single Dose of Mepolizumab in Patients with Severe Non-Allergic Eosinophilic Asthma: A Short Report
by: Virginija Kalinauskaite-Zukauske, et al.
Published: (2019-01-01) -
Cancer in myositis
by: Albert Selva-O'Callaghan, et al.
Published: (2020-01-01) -
Biological treatment options for eosinophilic asthma, with consideration of markers of eosinophilic inflammation as predictors of treatment efficacy
by: Aleksandra Niemiec, et al.
Published: (2024-02-01)